For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

Similar documents
For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: Sunitinib Other names: SUTENT

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

For the Patient: Methotrexate Other names: MTX

For the Patient: CAP. Capecitabine. Uses:

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

ABOUT THIS MEDICATION

For the Patient: ULUAVPMTN

For the Patient: LUSCTOP

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

For the Patient: LUAVPEM

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: LUAVNP

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Mitoxantrone Other names:

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: LUPUPE (Carboplatin Option)

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: LUAVPG (Carboplatin Option)

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: Paclitaxel Other names: TAXOL

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: LUSCPE

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: LUAJPC

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: LUPUPE

For the Patient: LUAVPG

ABOUT THIS MEDICATION

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

For the Patient: LUAVPP

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

For the Patient: Olaparib tablets Other names: LYNPARZA

For the Patient: Rituximab injection Other names: RITUXAN

ABOUT THIS MEDICATION

For the Patient: GDP-R Other names: LYGDPR

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

This therapy is being given to treat your cancer of the anal canal with the intention of cure.

ABOUT THIS MEDICATION

For the Patient: Lenalidomide Other names: REVLIMID

ABOUT THIS MEDICATION

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

ABOUT THIS MEDICATION

For the Patient: LULAPERT

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin and bevacizumab are drugs given to treat colon or rectal cancer.

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin, and panitumumab are drugs given to treat metastatic colorectal cancer.

For the Patient: GOOVDDCAT

For the Patient: GOOVCATM

For the Patient: GOOVCATR

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: SAAJAP

GI = GastroIntestinal FIRINOX = Fluorouracil, Irinotecan, Infusional fluorouracil, Oxaliplatin

For the Patient: LUAVDC

For the Patient: LUSCCAV

For the Patient: Vemurafenib Other names: ZELBORAF

ABOUT THIS MEDICATION

INTENDED BENEFITS You are being asked to take these drugs as a treatment to reduce the risk of recurrence of cancer of the stomach or esophagus.

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: GOCXCATB

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

For the Patient: UMYLDREL

For the Patient: GUBEP

For the Patient: LUOTPAC

For the Patient: ACTW Other names: BRAJACTW

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

For the Patient: DC. D Docetaxel (TAXOTERE ) C Cyclophosphamide

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

Treatment Plan: Drugs:

For the Patient: USMAVFIPI

For the Patient: ACD

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib

For the Patient: GUPDOCADT

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

Docetaxel (Taxotere )

For the Patient: LYEPOCHR Other Names: DA-EPOCHR

Transcription:

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine GI = GastroIntestinal AV = Advanced TZCAP = Temozolomide, Capecitabine ABOUT THIS MEDICATION What are these drugs used for? Temozolomide and capecitabine are drugs given to treat neuroendocrine tumours of the pancreas. How do these drugs work? Temozolomide and capecitabine work by interfering with dividing cells and preventing an increase in the number of cancer cells. INTENDED BENEFITS This therapy is being given to destroy and/or limit the growth of cancer cells in your body. This treatment may improve your current symptoms, and delay the onset of new symptoms. It may take several treatments before your doctor can judge whether or not this treatment is helping. TREATMENT SUMMARY How are these drugs given? Capecitabine is a tablet that you take by mouth. It is usually taken twice a day, about 10-12 hours apart, with equal numbers of tablets taken at each dose. It is started on day one (1) of treatment and is given for 14 days in a row. Temozolomide is a capsule that you take by mouth. It is usually taken once a day. It is started on day ten (10) of treatment and is given for five days in a row. When you have finished the medication, you will be given a rest period. The medications will then be started again 28 days following the first day of your treatment. This 28 day period of time is called a cycle. The cycle is repeated as long as you are benefiting from treatment and not having too many side effects, as determined by your oncologist. The calendar on the following page outlines how the medications are given each 28 days cycle. BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 1/8

C Y C L E 1 DATE TREATMENT PLAN Week 1 Capecitabine orally a.m. and p.m. with food for 7 days Week 2 Capecitabine orally a.m. and p.m. with food for 7 days Temozolomide orally once daily on an empty stomach for 5 days, from day 10 to 14. Week 3 no treatment Week 4 no treatment C Y C L E 2 DATE TREATMENT PLAN Week 1 Capecitabine orally a.m. and p.m. with food for 7 days Week 2 Capecitabine orally a.m. and p.m. with food for 7 days Temozolomide orally once daily on an empty stomach for 5 days, from day 10 to 14. Week 3 no treatment Week 4 no treatment The cycles are repeated as long as you are benefiting from treatment and not having too many side effects. What will happen when I get my drugs? A blood test is done each cycle, on or before the first day of each 28 day treatment cycle. The dose and timing of your chemotherapy may be changed based on your blood counts and / or other side effects. BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 2/8

SIDE EFFECTS AND WHAT TO DO ABOUT THEM Unexpected and unlikely side effects can occur with any drug treatment. The ones listed below are particularly important for you to be aware of as they are directly related to the common actions of the drugs in your treatment plan. Your doctor will review the risks of treatment and possible side effects with you before starting treatment. The pharmacist will review possible side effects of the drugs and how to manage those side effects with you on the day you receive your first treatment. SERIOUS SIDE EFFECTS DURING TREATMENT Nausea and vomiting may occur. Hand-foot skin reaction may occur very commonly during capecitabine treatment. The palms of your hands and soles of your feet may tingle, become red, numb, painful, or swollen. Skin may also become dry or itchy. You may not be able to do your normal daily activities if blisters, severe pain or ulcers occur. MANAGEMENT You may be given a prescription for an antinausea drug(s) to take before your chemotherapy treatment and/or at home. It is easier to prevent nausea than treat it once it has occurred, so follow directions closely. Taking your dose on an empty stomach, at least one hour before or after you eat, may help to reduce nausea. Drink plenty of liquids. Eat and drink often in small amounts. Try the ideas in Food Choice to Control Nausea*. Avoid tight-fitting shoes or rubbing pressure to hands and feet, such as that caused by heavy activity. Clean hands and feet with lukewarm water and gently pat to dry; avoid hot water. Apply lanolin-containing creams (eg. BAG BALM, UDDERLY SMOOTH ) to hands and feet liberally and often. Tell your cancer doctor at the next visit if you have any signs of hand-foot skin reaction. Stop taking capecitabine and call your cancer doctor if the skin reaction is painful, as your dose may need to be changed. Taking a lower dose does not affect the usefulness of capecitabine. BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 3/8

SERIOUS SIDE EFFECTS DURING TREATMENT Diarrhea may occur during your treatment. Sore mouth may occur commonly during treatment. Mouth sores can occur on the tongue, the sides of the mouth or in the throat. Mouth sores or bleeding gums can lead to an infection. Your white blood cells will decrease 3 4 weeks after your treatment. They usually return to normal within 2 weeks. White blood cells protect your body by fighting bacteria (germs) that cause infection. When they are low, you are at greater risk of having an infection. MANAGEMENT To help diarrhea: Drink plenty of fluids Eat and drink often in small amounts Eat low fibre foods and avoid high fibre foods as outline in Coping with Diarrhea*. If you have an increase of less than 4 stools per day more than normal, or a mild increase in ostomy output, start the following: Loperamide (IMODIUM ) 2 mg, take 2 tablets (4 mg) to start, followed by 1 tablet (2 mg) every 4 hours, or after each unformed stool to a maximum of 8 tablets (16 mg) daily, unless otherwise directed by a physician Stop taking capecitabine and call your cancer doctor if you have four stools a day more than usual or diarrhea during the night, or a moderate increase in ostomy output, as your capecitabine dose may need to be changed. Note: If lactose in milk usually gives you diarrhea, the lactose in the tablet may be causing your diarrhea. Take LACTAID tablets just before your capecitabine dose Brush your teeth gently after eating and at bedtime with a very soft toothbrush. If your gums bleed, use gauze instead of a brush. Use baking soda instead of toothpaste. Make a mouthwash with ½ teaspoon baking soda or salt in 1 cup warm water and rinse several times a day. Try soft, bland foods like puddings, milkshakes and cream soups. Avoid spicy, crunchy or acidic food, and very hot or cold foods. Try ideas in Easy to Chew, Easy to Swallow Food Ideas*. To help prevent infection: Wash your hands often and always after using the bathroom. Take care of your skin and mouth. Avoid crowds and people who are sick. Call your doctor immediately at the first sign of an infection such as fever (over 100ºF or 38ºC by an oral thermometer), chills, cough, or burning when you pass urine. BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 4/8

SERIOUS SIDE EFFECTS DURING TREATMENT Your platelets may decrease 3 4 weeks after your treatment. They usually return to normal within 2 weeks. Platelets help to make your blood clot when you hurt yourself. You may bruise or bleed more easily than usual. MANAGEMENT To help prevent bleeding problems: Try not to bruise, cut, or burn yourself. Clean your nose by blowing gently. Do not pick your nose. Avoid constipation. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Maintain good oral hygiene. Some medications such as ASA (e.g. ASPIRIN ) or ibuprofen (e.g. ADVIL ) may increase your risk of bleeding. Do not stop taking any medication that has been prescribed by your doctor (e.g. ASA for your heart). For minor pain, try acetaminophen (e.g. TYLENOL ) first, but occasional use of ibuprofen may be acceptable. OTHER SIDE EFFECTS MANAGEMENT DURING TREATMENT Headache may occur. Take acetaminophen (e.g. TYLENOL ) to decrease or stop headache. Sugar control may be affected in diabetics. Check your blood sugar regularly if you are diabetic. Tiredness and lack of energy may occur. Do not drive a car or operate machinery if you are feeling tired. Try the ideas in Your bank of energy savings: How people with cancer can handle fatigue.* Your skin may sunburn easily. To help prevent sunburn: Avoid direct sunlight. Wear a hat, long sleeves and long pants or skirt outside on sunny days. Apply a sun block lotion with an SPF (sun protection factor) of at least 30. Refer to Your Medication Sun Sensitivity and Sunscreens* or the BC Health Guide for more information. After sun exposure, if you have a severe sunburn or skin reaction such as itching, rash, or swelling, contact your doctor. Hair loss is rare with both temozolomide and Use a gentle shampoo and soft brush. capecitabine. If it does occur, your hair will Care should be taken with use of hair grow back once you stop treatment. Colour spray, bleaches, dyes and perms. and texture may change. *Please ask your chemotherapy nurse, pharmacist or dietician for a copy. BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 5/8

Special note: Heart Problems: Serious heart problems can occur when starting capecitabine. These can rarely be fatal. Problems such as chest pain, heart attack, abnormal heart rhythm, or heart failure can occur. Having a history of heart problems with fluorouracil, a related chemotherapy drug, is a risk factor, as is having a history of prior angina (heart pain) or heart attack. Seek medical attention promptly if you experience feelings of heavy pressure or pain in the chest, trouble breathing, significant worsening leg swelling, or marked lightheadedness. These symptoms can occur within days after starting capecitabine. If your symptoms are severe, you may need to call for emergency help. INSTRUCTIONS FOR THE PATIENT Tell your doctor if you have ever had an unusual or allergic reaction to fluorouracil (5FU, ADRUCIL ) or to dacarbazine (DTIC ) before taking capecitabine or temozolomide. The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of capecitabine or temozolomide. If you vomit after taking capecitabine or temozolomide, do not take another dose. Call your doctor during office hours for advice. Store capecitabine tablets and temozolomide capsules out of the reach of children, at room temperature and away from heat, light and moisture. Both capecitabine and temozolomide contain lactose. Temozolomide may cause sterility in men and menopause in women. Men taking temozolomide are advised not to father a child during or for 6 months after treatment. If you plan to have children, discuss this with your doctor before being treated with temozolomide. Capecitabine and temozolomide may damage sperm and may harm the baby if used during pregnancy. It is best to use birth control while being treated with capecitabine and temozolomide. Tell your doctor right away if you or your partner becomes pregnant. Do not breast feed during treatment. Tell doctors, dentists, and other health professionals that you are being treated with capecitabine and temozolomide before you receive any treatment from them. Capecitabine Capecitabine is taken by mouth twice a day, about 10-12 hours apart, with equal numbers of tablets taken at each dose. You may be given tablets of more than one strength to make the right dose. Capecitabine should be taken within 30 minutes following the end of a meal (breakfast and dinner) with a glass of water. It is usually given for 14 days, followed by a 14 day break. If you miss a dose of capecitabine, take it as soon as you can if it is within 6 hours of the missed dose. If it is over 6 hours since the missed dose, skip the missed dose and go back to the usual dosing time. Let your doctor know during office hours if you have missed a dose. Sometimes capecitabine treatment has to be stopped for a short time because of side effects. When you restart capecitabine treatment, do not make up for the missed dose; instead, take as directed by your cancer doctor and finish the treatment on the same day as originally planned. For example, if you stop on day 3 of your 14-day treatment course and then restart at a later day, you would still take the last dose on day 14. You may be told to take a different dose and you may have extra tablets left over. Return the extra tablets to the clinic at your next visit. Taking a lower dose does not affect the usefulness of capecitabine. BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 6/8

Temozolomide Temozolomide is taken by mouth once a day, on an empty stomach (30 60 minutes before a meal or 2 hours after a meal). You may be given capsule of more than one strength to make the right dose. You will be given a prescription for anti-nausea medication to take before your temozolomide dose. Unless your doctor gives you other directions, take each dose in the morning. Swallow the capsule whole. Do not open or chew the capsules. If you miss a dose of temozolomide, take it as soon as you can if it is within 12 hours of the missed dose. If it is over 12 hours since your missed dose, skip the missed dose and go back to your usually dosing times. Call your doctor during office hours to ask about making up the missed dose. Medication Interactions Other drugs such as warfarin (COUMADIN ), phenytoin (DILANTIN ), and fosphenytoin (CEREBYX ) may interact with capecitabine. Other drugs such as valproic acid (DEPAKENE ) may interact with temozolomide. Tell your doctor if you are taking this or any other drugs as you may need extra blood tests or your dose may need to be changed. Check with your doctor or pharmacist before you start taking any new drugs. THE FOLLOWING INFORMATION IS VERY IMPORTANT STOP TAKING CAPECITABINE AND TEMOZOLOMIDE AND SEE YOUR DOCTOR OR GET EMERGENCY HELP IMMEDIATELY IF YOU HAVE: Signs of an infection such as fever (over 100ºF or 38ºC by an oral thermometer); chills; cough; pain or burning when you pass urine. Signs of bleeding problems such as black tarry stools; blood in urine; pinpoint red spots on skin. Signs of heart or lung problems such as fast or uneven heartbeat, chest pain, chest pressure, shortness of breath or difficulty in breathing, swelling of ankles, or fainting. Signs of a blood clot such as tenderness or hardness over a vein, calf swelling and tenderness, sudden onset of cough, chest pain or shortness of breath. Seizures, memory loss (amnesia) or loss of consciousness with or without confusion, headache, or changes in eyesight. Severe muscle weakness or paralysis. Uncontrolled nausea, vomiting or diarrhea. BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 7/8

SEE YOUR DOCTOR AS SOON AS POSSIBLE (DURING OFFICE HOURS) IF YOU HAVE: Painful hand-foot skin reaction such as painful redness, peeling, tingling, numbness, swelling or blistering of the palms of your hands and/or bottoms of your feet. If there is a delay in seeing your doctor, stop taking your capecitabine tablets until you are seen or have discussed with your doctor Diarrhea with four stools a day more than usual, or diarrhea during the night. Nausea that causes you to eat a lot less than usual or vomiting more than 2 times in 24 hours. Painful redness, swelling or sores on your lips, tongue, mouth or throat. Signs of liver problems such as yellow eyes or skin, white or clay-coloured stools. Signs of anemia such as unusual tiredness or weakness. Severe abdominal or stomach cramping or pain. CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING CONTINUE OR BOTHER YOU: Painless hand-foot skin reaction such as redness, peeling, tingling, numbness, swelling or blistering of the palms of your hands and/or bottoms of your feet, Painless redness, swelling or sores on your lips, tongue, mouth or throat. Pain in your stomach or abdomen. Headache not controlled by acetaminophen. For diabetics: uncontrolled blood sugars Easy bruising or bleeding Loss of appetite or constipation. Skin rash or itching. Changes in fingernails or toenails. Heartburn; mild to moderate abdominal or stomach pain. Watery, irritated eyes. If you experience symptoms or changes in your body that have not been described above but worry you, or if any symptoms are severe, contact: at telephone number: BC Cancer Agency Protocol Summary (Patient Version) GIAVTZCAP 8/8